Patents

US 12751938 B2: Therapeutic uses of inhibitors of the RNA-binding protein HuR

Granted
2026-10-06
Filed
2021-03-22 application 17914287
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present technology is directed to methods of treatment utilizing inhibitors of HuR interaction with RNA, where the inhibitors are of Formula I where R1 is; and X1 is OH, NH—OH, or 0-(C1-C8 unsubstituted alkyl).

Source: PTBLXML, file of 2026-10-06 (ipgb20261006.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
UNIVERSITY OF KANSAS 437 patentsUS company or organizationLawrence, KSUniversity of Kansas College or university EXACT high confidence: identical full name and state
UNIVERSITY OF KANSAS Federal lobbying client EXACT high confidence: identical full name and state
PTBLXML, file of 2026-10-06

Inventors

InventorPlacePatentsPerson pageSource
Liang XuLawrence, KS8PTBLXML, file of 2026-10-06
Xiaoqing WuLawrence, KSPTBLXML, file of 2026-10-06
Lan LanLawrence, KSPTBLXML, file of 2026-10-06
Jeff AubeChapel Hill, KSPTBLXML, file of 2026-10-06

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/381PTBLXML, file of 2026-10-06
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/18PTBLXML, file of 2026-10-06

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.